Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion type Assertion NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_head.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion wasGeneratedBy ECO_0000203 NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_provenance.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion wasDerivedFrom befree-20140225 NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_provenance.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion SIO_000772 20629990 NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_provenance.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion evidence source_evidence_literature NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_provenance.
- NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_assertion description "[Moreover, HCC patients with unmethylated CD147 promoter had a significantly higher recurrence rate (88.1%versus 58.3%; P < 0.05) and death rate (83.3%versus 50.0%; P < 0.05) than patients with methylated CD147 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907762.RALyVFacwyrtzp1MJMkT4YqI-TKqc7Upy-QcIilYBdAJo130_provenance.